Dimerization drives EGFR endocytosis through two sets of compatible endocytic codes

被引:21
作者
Wang, Qian
Chen, Xinmei
Wang, Zhixiang [1 ]
机构
[1] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada
基金
加拿大健康研究院;
关键词
EGF receptor; Endocytosis; Dimerization; Dual endocytic codes; EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; ERBB RECEPTORS; MONOCLONAL-ANTIBODIES; SIGNAL-TRANSDUCTION; DOWN-REGULATION; IN-VIVO; ACTIVATION; NEU; HETERODIMERS;
D O I
10.1242/jcs.160374
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have shown previously that epidermal growth factor (EGF) receptor (EGFR) endocytosis is controlled by EGFR dimerization. However, it is not clear how the dimerization drives receptor internalization. We propose that EGFR endocytosis is driven by dimerization, bringing two sets of endocytic codes, one contained in each receptor monomer, in close proximity. Here, we tested this hypothesis by generating specific homo- or hetero-dimers of various receptors and their mutants. We show that ErbB2 and ErbB3 homodimers are endocytosis deficient owing to the lack of endocytic codes. Interestingly, EGFR-ErbB2 or EGFR-ErbB3 heterodimers are also endocytosis deficient. Moreover, the heterodimer of EGFR and the endocytosis-deficient mutant EGFR Delta 1005-1017 is also impaired in endocytosis. These results indicate that two sets of endocytic codes are required for receptor endocytosis. We found that an EGFR-PDGFR beta heterodimer is endocytosis deficient, although both EGFR and PDGFR beta homodimers are endocytosis-competent, indicating that two compatible sets of endocytic codes are required. Finally, we found that to mediate the endocytosis of the receptor dimer, the two sets of compatible endocytic codes, one contained in each receptor molecule, have to be spatially coordinated.
引用
收藏
页码:935 / 950
页数:16
相关论文
共 50 条
[1]   Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo [J].
Allen, Stephanie D. ;
Garrett, Joan T. ;
Rawale, Sharad V. ;
Jones, Audra L. ;
Phillips, Gary ;
Forni, Guido ;
Morris, John C. ;
Oshima, Robert G. ;
Kaumaya, Pravin T. P. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (01) :472-482
[2]   Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases [J].
Bae, Jae Hyun ;
Schlessinger, Joseph .
MOLECULES AND CELLS, 2010, 29 (05) :443-448
[3]   MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185 [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
CELL, 1986, 45 (05) :649-657
[4]  
Baulida J, 1996, J BIOL CHEM, V271, P5251
[5]   EGFR family: Structure physiology signalling and therapeutic targets [J].
Burgess, Antony W. .
GROWTH FACTORS, 2008, 26 (05) :263-274
[6]  
CANFIELD WM, 1991, J BIOL CHEM, V266, P5682
[7]   A NEU ACQUAINTANCE FOR ERBB3 AND ERBB4 - A ROLE FOR RECEPTOR HETERODIMERIZATION IN GROWTH SIGNALING [J].
CARRAWAY, KL ;
CANTLEY, LC .
CELL, 1994, 78 (01) :5-8
[8]  
CHEN WJ, 1990, J BIOL CHEM, V265, P3116
[9]   EGF-ERBB signalling: towards the systems level [J].
Citri, Ami ;
Yarden, Yosef .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (07) :505-516
[10]   Dissecting the functions of proteins and pathways using chemically induced dimerization [J].
Clackson, Tim .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (06) :440-442